Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 9, 2014, Pages 1505-1510

  Samonis, G ^a   Korbila, I P ^b   Maraki, S ^d   Michailidou, I ^b   Vardakas, K Z ^b   Kofteridis, D ^a   Dimopoulou, D ^a   Gkogkozotou, V K ^a   Falagas, M E ^b,c,e  

^a UNIVERSITY OF CRETE   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG USE; GREECE; HUMAN; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; PUS; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; SPECIES DISTRIBUTION; TREND STUDY; URINE; DRUG EFFECTS; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; TERTIARY CARE CENTER; TRENDS;

ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GREECE; HUMANS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84906060625     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2097-8     Document Type: Article

References (35)

1. Cohen-Nahum K, Saidel-Odes L, Riesenberg K et al (2010) Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection 38(1):41-46
2. Falagas ME, Kavvadia PK, Mantadakis E et al (2006) Morganella morganii infections in a general tertiary hospital. Infection 34(6):315-321 (Pubitemid 44968923)
3. Wu YM, Hsu PC, Yang CC et al (2013) Serratia marcescens meningitis: epidemiology, prognostic factors and treatment outcomes. J Microbiol Immunol Infect 46(4):259-265
4. Maltezou HC, Tryfinopoulou K, Katerelos P et al (2012) Consecutive Serratia marcescens multiclone outbreaks in a neonatal intensive care unit. Am J Infect Control 40(7):637-642
5. Villa J, Alba C, Barrado L et al (2012) Long-term evolution of multiple outbreaks of Serratia marcescens bacteremia in a neonatal intensive care unit. Pediatr Infect Dis J 31(12):1298-1300
6. Zavascki AP, Carvalhaes CG, da Silva GL et al (2012) Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol 33(6):627-630
7. Miró E, Agüero J, Larrosa MN et al (2013) Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis 32(2):253-259
8. Rodríguez-Baño J, Miró E, Villar M et al (2012) Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC beta-lactamases. J Infect 64(2):176-183
9. O'Hara CM, Brenner FW, Miller JM (2000) Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 13(4):534-546
10. Landman D, Georgescu C, Martin DA et al (2008) Polymyxins revisited. Clin Microbiol Rev 21(3):449-465
11. Leclercq R, Cantón R, Brown DF et al (2013) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19(2):141-160
12. Sud IJ, Feingold DS (1970) Mechanism of polymyxin B resistance in Proteus mirabilis. J Bacteriol 104(1):289-294
13. Falagas ME, Kasiakou SK (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40(9):1333-1341 (Pubitemid 40570245)
14. Li J, Nation RL, Milne RW et al (2005) Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25(1):11-25 (Pubitemid 40023341)
15. Falagas ME, Rafailidis PI, Matthaiou DK (2010) Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 13(4-5):132-138
16. Matthaiou DK, Michalopoulos A, Rafailidis PI et al (2008) Risk factors associated with the isolation of colistin-resistant gramnegative bacteria: a matched case-control study. Crit Care Med 36(3):807-811
17. Samonis G, Matthaiou DK, Kofteridis D et al (2010) In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 50(12):1689-1691
18. Farmer JJ III, Boatwright KD, Janda JM (2007) Enterobacteriaceae: introduction and identification. In: Baron EJ, Murray PR, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology. ASM Press, Washington, pp 649-669
19. Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. CLSI, Wayne, PA, USA
20. Dean A, Sullivan K, Soe M (2008) OpenEpi: open source epidemiologic statistics for public health. Updated 2008/04/06; version 2.2.1. Home page at: http://www.openepi.com
21. Lepper PM, Grusa E, Reichl H et al (2002) Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46(9):2920-2925
22. Lesch CA, Itokazu GS, Danziger LH et al (2001) Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis 41(3):149-154 (Pubitemid 34036505)
23. Liakopoulos A, Miriagou V, Katsifas EA et al (2012) Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill 17(11). pii: 20117
24. Miyakis S, Pefanis A, Tsakris A (2011) The challenges of antimicrobial drug resistance in Greece. Clin Infect Dis 53(2):177-184
25. Singh N, Yu VL (2000) Rational empiric antibiotic prescription in the ICU. Chest 117(5):1496-1499
26. Vatopoulos A (2008) High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill 13(4). pii: 8023
27. Willemsen I, Groenhuijzen A, Bogaers D et al (2007) Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 51(3):864-867 (Pubitemid 46355268)
28. Karageorgopoulos DE, Kelesidis T, Kelesidis I et al (2008) Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62(1):45-55 (Pubitemid 351865873)
29. Kelesidis T, Karageorgopoulos DE, Kelesidis I et al (2008) Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62(5):895-904
30. Hayakawa K, Marchaim D, Divine GW et al (2012) Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center. Int J Infect Dis 16(9):e646-e648
31. Hanulík V, Suchánková H, Urbánek K et al (2013) Effect of colistin consumption and prevalence of colistin-resistant bacteria. Klin Mikrobiol Infekc Lek 19(2):52-55
32. Vourli S, Tsorlini H, Katsifa H et al (2006) Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Clin Microbiol Infect 12(7):691-694 (Pubitemid 43842496)
33. Miriagou V, Tzouvelekis LS, Flevari K et al (2007) Providencia stuartii with VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 60(1):183-184
34. Tsakris A, Ikonomidis A, Poulou A et al (2008) Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect 14(6):588-594 (Pubitemid 351639074)
35. Muller A, Monnet DL, Talon D et al (2006) Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol 61(5):585-591